Menu

Calliditas Therapeutics AB (publ) CALT

Full chart Compare
Set alert

Price alert · CALT

All alert types
40.00 0.00 (+0.00%)

At closeSep 20, 2024, 4:00 PM EDT

40.00 Day range 43.00

52-week range unavailable

Revenue & Expenses

Other Operating Income → Expenses: $43.47MExpenses → Selling, General & Admin: $1.06BExpenses → Research & Development: $502.22MExpenses → Interest Expense: $83.96MExpenses → Income Tax: $9.17MGross Profit → Expenses: $1.15BRevenue → Gross Profit: $1.15BRevenue → Cost of Revenue: $60.46MNet Loss → Expenses: $466.19MOther Operating Income$43.47MGross Profit$1.15BNet Loss$466.19MCost of Revenue$60.46MExpenses$1.66BSelling, General & Admin$1.06BResearch & Development$502.22MInterest Expense$83.96MIncome Tax$9.17MRevenue$1.21B

Latest period ending Dec 31, 2023 · select a line to chart its full history

CALT annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
1.21B802.88M229.35M874.00K184.83M
1.15B787.68M229.35M874.00K184.83M
-373.06M-421.94M-524.46M-379.72M-28.02M
-466.19M-412.27M-500.29M-433.49M-32.58M
-17.38-15.56-19.68-19.32-1.76
CALT annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
973.73M1.25B955.51M996.30M753.54M
1.86B1.95B1.46B1.46B845.20M
1.52B1.19B451.63M207.61M57.13M
966.60M728.82M213.22M878.00K0
334.81M766.26M1.01B1.21B788.07M
CALT annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-434.65M-311.35M-461.59M-309.18M-71.01M
-13.74M-5.14M-24.34M-172.61M-18.07M
199.65M575.99M435.16M768.56M198.84M
-248.75M259.49M-50.77M286.77M109.75M